This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Pfizer Vaccines, Lcc. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Jakir Hussain Ullah: Innovator in Vaccine Development
Introduction
Jakir Hussain Ullah is a prominent inventor based in Sandwich, GB. He has made significant contributions to the field of vaccine development, particularly in the area of PCSK9-mediated disorders. With a total of 3 patents to his name, Ullah is recognized for his innovative approaches to medical treatments.
Latest Patents
Ullah's latest patents focus on the development of a PCSK9 vaccine. The first patent describes the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment, or alleviation of PCSK9-mediated disorders. This invention also outlines methods for the production of these medicaments, immunogenic compositions, and their use in medicine. The second patent reiterates similar concepts, emphasizing the importance of these immunogens in combating PCSK9-related health issues.
Career Highlights
Ullah is currently associated with Pfizer Vaccines, LLC, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against diseases linked to PCSK9, showcasing his commitment to improving public health through innovative solutions.
Collaborations
Ullah has collaborated with notable colleagues in his field, including Brian Robert Champion and Leonard Gabriel Contillo, Jr. These partnerships have further enhanced his research capabilities and contributed to the success of his projects.
Conclusion
Jakir Hussain Ullah stands out as a key figure in vaccine innovation, particularly with his work on PCSK9 vaccines. His contributions are vital to the advancement of medical science and the development of effective treatments for complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile